实用医学杂志
實用醫學雜誌
실용의학잡지
The Journal of Practical Medicine
2015年
18期
2960-2962
,共3页
细胞色素氧化酶P4501A1%多态性%甲氨蝶呤%急性淋巴细胞白血病
細胞色素氧化酶P4501A1%多態性%甲氨蝶呤%急性淋巴細胞白血病
세포색소양화매P4501A1%다태성%갑안접령%급성림파세포백혈병
CYP1A1%Polymorphism%Methotrexate%Acute lymphocytic leukumia
目的:探讨细胞色素氧化酶P4501A1(CYP1A1)基因多态性与急性淋巴细胞白血病(ALL)儿童大剂量甲氨蝶呤(HD-MTX)化疗后毒副作用的关系。方法:用RT-PCR-变性梯度凝胶电泳(DGGE)及DNA测序技术对51例ALL儿童CYP1A1进行多态性筛查,统计患儿HD-MTX毒副作用表现,分析两者相关性。结果:仅筛查到一个多态位点,即A4889G,4889A/G 各基因型与患儿毒副作用发生均无关(P >0.05),高危型患儿较标危型患儿更易发生血小板减少(P <0.05)。结论:CYP1A1 A4889G多态性与ALL儿童HD-MTX化疗后各毒副反应无关,血小板减少的发生可能与患儿危险度相关。
目的:探討細胞色素氧化酶P4501A1(CYP1A1)基因多態性與急性淋巴細胞白血病(ALL)兒童大劑量甲氨蝶呤(HD-MTX)化療後毒副作用的關繫。方法:用RT-PCR-變性梯度凝膠電泳(DGGE)及DNA測序技術對51例ALL兒童CYP1A1進行多態性篩查,統計患兒HD-MTX毒副作用錶現,分析兩者相關性。結果:僅篩查到一箇多態位點,即A4889G,4889A/G 各基因型與患兒毒副作用髮生均無關(P >0.05),高危型患兒較標危型患兒更易髮生血小闆減少(P <0.05)。結論:CYP1A1 A4889G多態性與ALL兒童HD-MTX化療後各毒副反應無關,血小闆減少的髮生可能與患兒危險度相關。
목적:탐토세포색소양화매P4501A1(CYP1A1)기인다태성여급성림파세포백혈병(ALL)인동대제량갑안접령(HD-MTX)화료후독부작용적관계。방법:용RT-PCR-변성제도응효전영(DGGE)급DNA측서기술대51례ALL인동CYP1A1진행다태성사사,통계환인HD-MTX독부작용표현,분석량자상관성。결과:부사사도일개다태위점,즉A4889G,4889A/G 각기인형여환인독부작용발생균무관(P >0.05),고위형환인교표위형환인경역발생혈소판감소(P <0.05)。결론:CYP1A1 A4889G다태성여ALL인동HD-MTX화료후각독부반응무관,혈소판감소적발생가능여환인위험도상관。
Objective To investigate the association between CYP1A1 gene polymorphism and toxicities related to high-does methotrexate of childhood acute leukemia. Methods The SNPs were detected by reverse transcriptional (RT)-PCR-denaturing gradient gel elelctrphoresis combined with direct sequencing in 51 children with acute leukemia. Toxicities were collected thereby. Results Only one SNP,A4889G, was screened in CYP1A1. A4889G polymorphism was not associated with all the toxicities (P > 0.05). High-risk ALL children were more likely to increase the risk of thrombocytopenia compared with standard-risk ALL (P< 0.05). Conclusions CYP1A1 A4889G polymorphism may be not association with all toxicities after HD-MTX ,but the thrombocytopenia may be relevant to the risk degree of ALL children.